Video Experimental Relacionado
Updated: Aug 26, 2026
09:33
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
La neoplasia endocrina múltiple tipo 1 tiene un mapa genético en el cromosoma 11 y se pierde en el insulinoma
C Larsson1, B Skogseid, K Oberg
1Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden.
Nature
|March 3, 1988
Resumen
La neoplasia endocrina múltiple tipo 1 (MEN-1) es un trastorno hereditario. Los estudios genéticos vincularon a MEN-1 con el cromosoma 11, revelando una mutación recesiva desenmascarada durante el desarrollo del tumor.
Área de la Ciencia:
- Genética La genética.
- Endocrinología Endocrinología.
- Oncología Oncología.
Sus antecedentes:
- La neoplasia endocrina múltiple tipo 1 (MEN-1) es un trastorno hereditario autosómico dominante.
- MEN-1 causa hiperplasia de las glándulas paratiroides, la pituitaria anterior y el páncreas endocrino.
- Comprender la base genética de MEN-1 es crucial para el diagnóstico y el manejo.
Objetivo del estudio:
- Para mapear el locus del gen MEN-1.
- Para investigar los mecanismos genéticos subyacentes a la tumorigénesis de MEN-1.
Principales métodos:
- Estudios de vínculos genéticos basados en la familia.
- Genotipización de tejidos constitucionales y tumorales.
- Comparación de marcadores genéticos, incluido el gen de la fosforilasa muscular humana.
Principales resultados:
- El locus MEN-1 fue mapeado en el cromosoma 11.
- Se demostró una estrecha vinculación con el gen de la fosforilasa muscular humana.
- La tumorigénesis en MEN-1 implica el desenmascaramiento de una mutación recesiva en el locus MEN-1.
Conclusiones:
- El gen MEN-1 se encuentra en el cromosoma 11.
- El desarrollo de los tumores asociados a MEN-1 implica un mecanismo de dos golpes, con una mutación recesiva que se desenmascara.
Videos de Conceptos Relacionados
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...